Title:
スフィンゴシン1リン酸塩受容体拮抗薬
Document Type and Number:
Japanese Patent JP2012505920
Kind Code:
A
Abstract:
This disclosure relates to sphingosine-1-phosphate (S1P) receptor antagonists, compositions comprising the S1P receptor antagonists and methods for using and processes for making the S1P receptor antagonists. In particular, this disclosure relates to sphingosine-1-phosphate 1 (S1P1) receptor antagonists, compositions comprising the S1P1 receptor antagonist and methods for using the S1P1 receptor antagonist, such as in the treatment of cancer, and processes for making the S1P1 receptor antagonists.
More Like This:
Inventors:
Ibrahim, Mohammed Abdul Kadda
John, John Wong
Johnson, Henry William Beecroft
Kearney, Patrick
Leahy, James W.
Lewis, Gary Elle.
Noguchi, Robin Tammy
Eggplant, John M.
John, John Wong
Johnson, Henry William Beecroft
Kearney, Patrick
Leahy, James W.
Lewis, Gary Elle.
Noguchi, Robin Tammy
Eggplant, John M.
Application Number:
JP2011532293A
Publication Date:
March 08, 2012
Filing Date:
October 16, 2009
Export Citation:
Assignee:
Exelixis, Inc.
International Classes:
C07C237/04; A61K31/167; A61K31/222; A61K31/277; A61K31/341; A61K31/36; A61K31/381; A61K31/40; A61K31/401; A61K31/4015; A61K31/4025; A61K31/4035; A61K31/404; A61K31/405; A61K31/41; A61K31/415; A61K31/4164; A61K31/4178; A61K31/4184; A61K31/4192; A61K31/4196; A61K31/42; A61K31/421; A61K31/422; A61K31/426; A61K31/427; A61K31/438; A61K31/44; A61K31/4402; A61K31/4406; A61K31/4439; A61K31/445; A61K31/454; A61K31/455; A61K31/47; A61K31/472; A61K31/4725; A61K31/495; A61K31/496; A61K31/4965; A61K31/498; A61K31/502; A61K31/505; A61K31/506; A61K31/5375; A61K31/5377; A61K31/54; A61K31/541; A61K31/55; A61P35/00; A61P35/02; A61P43/00; C07C231/02; C07D207/06; C07D207/08; C07D207/14; C07D207/16; C07D207/20; C07D207/277; C07D207/327; C07D207/452; C07D209/08; C07D209/18; C07D209/42; C07D209/44; C07D209/48; C07D211/14; C07D211/58; C07D211/60; C07D213/56; C07D213/74; C07D213/81; C07D213/82; C07D215/06; C07D215/48; C07D215/50; C07D215/54; C07D217/04; C07D231/12; C07D231/14; C07D233/61; C07D233/64; C07D233/78; C07D235/14; C07D237/28; C07D239/26; C07D239/38; C07D239/42; C07D241/12; C07D241/24; C07D241/44; C07D249/08; C07D249/18; C07D257/04; C07D261/08; C07D261/14; C07D263/32; C07D265/30; C07D277/04; C07D277/20; C07D277/36; C07D295/14; C07D307/14; C07D307/24; C07D307/54; C07D307/68; C07D307/71; C07D317/60; C07D333/22; C07D333/24; C07D333/38; C07D333/40; C07D333/70; C07D401/04; C07D401/06; C07D401/12; C07D403/06; C07D403/12; C07D403/14; C07D405/06; C07D409/06; C07D409/14; C07D413/06; C07D417/06; C07D417/12; C07D491/113
Domestic Patent References:
| JP2003529558A | 2003-10-07 |
Foreign References:
| WO2002076968A1 | 2002-10-03 | |||
| WO2008080223A1 | 2008-07-10 | |||
| WO2007027742A2 | 2007-03-08 | |||
| WO2007003934A2 | 2007-01-11 | |||
| WO1999011657A1 | 1999-03-11 |
Attorney, Agent or Firm:
Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita
Takaaki Yasumura
Natsuki Morishita
Previous Patent: レニン−アンギオテンシンアルドステロン系関連疾病の治療用組成物及び...
Next Patent: 低酸素性損傷または虚血性損傷を治療しまたは予防するための組成物およ...
Next Patent: 低酸素性損傷または虚血性損傷を治療しまたは予防するための組成物およ...